Shots:
- INBRAIN Neuroelectronics has entered into a strategic collaboration with Microsoft to apply agentic AI powered by Microsoft’s cloud & data infrastructure to enhance real-time precision neurology & next-gen brain-computer interface (BCI) therapeutics
- The partnership will leverage Microsoft’s Azure AI infrastructure, incl. time-series large language models & data analytics with INBRAIN’s graphene-based neural platform, allowing adaptive, closed-loop interventions for neurological disorders
- INBRAIN’s neural platform provides high conductivity & biocompatibility to support the development of personalized, AI-enabled BCI therapeutics for data-driven modulation of neural circuits
Ref: Businesswire| Image: INBRAIN Neuroelectronics & Microsoft | Press Release
Related News:- Transition Bio Inks ~$500M Pact with Voyager Therapeutics to Develop Small Molecules for Neurodegenerative Diseases
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
